FrancophonIA/ELRC3.0 huggingface dataset:
English: A slight increase in incidence of supernumerary ribs, a variant in the normal developmental process, was observed in rat foetuses of dams exposed to raltegravir at approximately 4.4-fold human exposure at 400 mg twice daily based on AUC0-24 hr. No development effects were seen at 3.4-fold human exposure at 400 mg twice daily based on AUC0-24 hr.
Danish: En lille stigning i forekomsten af overtallige ribben, en variant i den normale udviklingsproces, blev set i rottefostre fra moderdyr, der havde været eksponeret for raltegravir i doser, der var cirka 4,4 gange højere end human eksponering ved 400 mg to gange dagligt baseret på AUC0-24t.
English: • antacids (an agent that counteracts or neutralises the acid in the stomach to relieve indigestion and heartburn)
Danish: • antacida (lægemidler, der modvirker eller neutraliserer mavesyren til lindring af fordøjelsesbesvær og halsbrand)
English: Myopathy and rhabdomyolysis
Danish: Myopati og rabdomyolyse
English: • This product does not require any special storage conditions.
Danish: • Dette lægemiddel kræver ingen særlige forholdsregler vedrørende opbevaringen.
English: Therefore, ISENTRESS should be used with caution in patients with severe hepatic impairment (see sections 4.4 and 5.2).
Danish: Derfor bør ISENTRESS anvendes med forsigtighed hos patienter med svært nedsat leverfunktion (se pkt.
English: In vitro studies indicate that raltegravir is not a substrate of cytochrome P450 (CYP) enzymes, does not inhibit CYP1A2, CYP2B6, CYP2C8, CYP2C9, CYP2C19, CYP2D6 or CYP3A, does not inhibit UDP glucuronosyltransferases (UGTs) 1A1 and 2B7, does not induce CYP3A4 and is not an inhibitor of P-glycoprotein (P-gp), breast cancer resistance protein (BCRP), organic anion-transporting polypeptides (OATP) 1B1, OATP1B3, organic cation transporters (OCT)1 and OCT2, or multidrug and toxin extrusion proteins (MATE)1 and MATE2-K. Based on these data, raltegravir is not expected to affect the pharmacokinetics of medicinal products that are substrates of these enzymes or transporters.
Danish: In vitro-studier indikerer, at raltegravir ikke er et substrat for CYP-enzymer, ikke hæmmer CYP1A2, CYP2B6, CYP2C8, CYP2C9, CYP2C19, CYP2D6 eller CYP3A, ikke hæmmer UDPglucuronosyltransferaserne (UGTerne) 1A1 og 2B7, ikke inducerer CYP3A4, og ikke er en hæmmer af P-glykoprotein (P-gp), brystcancer-resistent protein (BCRP), organiske anion-transporterende polypeptider (OATP) 1B1, OATP1B3, organiske kation-transportører (OCT)1 og OCT2 eller multidrug- og toksin-ekstrusionsproteiner (MATE)1 og MATE2-K.
English: 60 sachets, two 1 mL, two 3 mL and two 10 mL oral dosing syringes and 2 mixing cups.
Danish: 60 folieposer, to 1 ml, to 3 ml og to 10 ml doseringssprøjter til oral anvendelse og 2 blandebægre.
English: EU/1/07/436/006 EU/1/07/436/007 180 film-coated tablets (3 bottles of 60)
Danish: EU/1/07/436/006 EU/1/07/436/007 180 filmovertrukne tabletter (3 flasker a 60)
English: Two pack sizes are available: packs containing 1 bottle with 60 tablets, and multipacks comprising 3 bottles, each containing 60 tablets.
Danish: Der findes to pakningsstørrelser: pakninger med 1 flaske med 60 tabletter og multipakninger med 3 flasker med 60 tabletter i hver.
English: Co-administration of raltegravir 1,200 mg once daily with aluminium/magnesium and calcium carbonate containing antacids are likely to result in clinically meaningful reductions in the plasma trough levels of raltegravir.
Danish: Administration af raltegravir 1.200 mg en gang dagligt sammen med aluminium/magnesium- og calciumcarbonatholdige antacida vil sandsynligvis medføre klinisk relevant reduktion i raltegravirs dalkoncentration i plasma.
English: Patient demographics (gender, age and race) and baseline characteristics were comparable between the group receiving raltegravir 1,200 mg once daily and the group receiving raltegravir 400 mg twice daily.
Danish: Patientdemografi (køn, alder og race) og karakteristika ved baseline var sammenlignelige for den gruppe, der fik raltegravir 1.200 mg en gang dagligt, og gruppen, der fik raltegravir 400 mg to gange dagligt.
English: Therefore, raltegravir should be used with caution in patients with severe hepatic impairment (see sections 4.2 and 5.2).
Danish: Derfor bør raltegravir anvendes med forsigtighed hos patienter med svært nedsat leverfunktion (se pkt.
English: Randomisation was stratified by screening HIV RNA level (≤ 100,000 copies/mL; and > 100,000 copies/mL) and by hepatitis B or C status (positive or negative).
Danish: Randomisering blev stratificeret ved screening af hiv-RNA-koncentrationen (≤ 100.000 kopier/ml og > 100.000 kopier/ml) og ved hepatitis B- eller C-status (positiv eller negativ).
English: Weight based dosing, see dosing tables for the chewable tablet
Danish: Vægtbaseret dosering, se doseringstabellerne for tyggetabletten
English: ONCEMRK Study
Danish: ONCEMRK-studiet
English: 2 green (3 mL) syringes
Danish: 2 grønne (3 ml) sprøjter
English: • visual disturbance
Danish: • Synsforstyrrelser
English: No hepatic impairment study has been conducted with raltegravir 1,200 mg once daily, however, based on results with the 400 mg twice daily tablet, no clinically meaningful effect is expected for mild and moderate hepatic impairment.
Danish: Der er ikke udført studier af nedsat leverfunktion med raltegravir 1.200 mg en gang dagligt, men på basis af resultaterne med 400 mg to gange dagligt tabletten, forventes der ingen klinisk betydningsfuld effekt for let eller moderat nedsat leverfunktion.
English: 4 to less than 5
Danish: 4 til under 5
English: ISENTRESS 25 mg - bottle labeling
Danish: ISENTRESS 25 mg - flaskeetiket
English: (UGT1A1 inhibition)
Danish: (UGT1A1-hæmning)
English: 1 mixing cup (Using the tab on the mixing cup,
Danish: 1 blandebæger (Åbn låget ved hjælp af tappen på blandebægeret)
English: What Isentress contains The active substance is raltegravir.
Danish: Isentress indeholder: Aktivt stof: raltegravir.
English: Strong inducers of drug metabolizing enzymes (e.g., rifampicin) have not been studied with raltegravir 1,200 mg once daily, but could result in decreased raltegravir trough plasma levels; therefore, co-administration with raltegravir 1,200 mg once daily is not recommended.
Danish: Stærke inducere af lægemiddelmetaboliserende enzymer (f.eks. rifampicin) er ikke undersøgt sammen med raltegravir 1.200 mg en gang dagligt, men kan medføre nedsat dalkoncentration af raltegravir i plasma.
English: Tablet core - Microcrystalline cellulose - Hypromellose 2910 - Magnesium stearate - Croscarmellose sodium
Danish: Tabletkerne - Mikrokrystallinsk cellulose - Hypromellose 2910 - Magnesiumstearat - Croscarmellosenatrium
English: • Antacids (an agent that counteracts or neutralises the acid in the stomach to relieve indigestion and heartburn).
Danish: • antacida (lægemidler, der modvirker eller neutraliserer mavesyren til lindring af fordøjelsesbesvær og halsbrand).
English: 0.5 mL (5 mg) once daily
Danish: 0,5 ml (5 mg) en gang dagligt
English: tenofovir AUC  10 % tenofovir C24hr  13 % tenofovir Cmax ↓ 23 %
Danish: tenofovir AUC  10% tenofovir C24t  13% tenofovir Cmax ↓ 23%
English: tenofovir AUC  10% tenofovir C24hr  13% tenofovir Cmax ↓ 23%
Danish: tenofovir AUC 10% tenofovir C24t 13% tenofovir Cmax ↓23%
English: No renal impairment study was conducted with raltegravir 1,200 mg once daily however, based on results with the 400 mg twice daily tablet, no clinically meaningful effect is anticipated.
Danish: Der er ikke udført studier af nedsat nyrefunktion med raltegravir 1.200 mg en gang dagligt, men på basis af resultaterne med 400 mg to gange dagligt tabletten, forventes der ingen klinisk betydningsfuld effekt.
English: Body weight Formulation
Danish: Kropsvægt
English: Co-administration of raltegravir (1,200 mg once daily) is not recommended.
Danish: Administration sammen med raltegravir (1.200 mg en gang dagligt) frarådes.
English: ANTI-RETROVIRAL Protease inhibitors (PI) atazanavir /ritonavir (raltegravir 400 mg Twice Daily)
Danish: ANTIRETROVIRALE LÆGEMIDLER Proteasehæmmere (PI) atazanavir /ritonavir (raltegravir 400 mg to gange dagligt)
English: 3 to less than 4
Danish: 3 til under 4
English: Table 5 Efficacy Outcome at Weeks 48 and 240
Danish: Tabel 5 Effektresultater ved uge 48 og 240
English: Raltegravir 1,200 mg QD and raltegravir 400 mg BID were administered with emtricitabine (+) tenofovir disoproxil fumarate.
Danish: Raltegravir 1.200 mg en gang dagligt og raltegravir 400 mg to gange dagligt blev administreret sammen med emtricitabin (+) tenofovirdisoproxilfumarat.
English: What you need to know before you take Isentress How to take Isentress
Danish: Det skal du vide, før du begynder at tage Isentress Sådan skal du tage Isentress
English: EU/1/07/436/001 EU/1/07/436/002 180 film-coated tablets (3 bottles of 60)
Danish: EU/1/07/436/001 EU/1/07/436/002 180 filmovertrukne tabletter (3 flasker a 60)
English: Geometric mean (%CV C12hr (nM)
Danish: Geometrisk middelværdi (%CV†) C12t (nM)
English: Chewable tablet 25 mg Pale yellow, round, chewable tablet with MSD corporate logo on one side and “473” on the other side.
Danish: Tyggetablet 25 mg Lysegul, rund tyggetablet med MSD-virksomhedslogo på den ene side og "473" på den anden side.
English: At the NOAEL, systemic exposure was similar to that at the clinical dose of 1,200 mg once daily.
Danish: Ved NOAEL (No Observable Adverse Effect Level) var den systemiske eksponering sammenlignelig med eksponeringen ved kliniske doser på 1.200 mg en gang dagligt.
English: Co-administration of raltegravir (400 mg twice daily and 1,200 mg once daily) with aluminium and/or magnesium containing antacids is not recommended.
Danish: Administration af raltegravir (400 mg to gange dagligt og 1.200 mg en gang dagligt) sammen med aluminium- og/eller magnesiumholdige antacida frarådes.
English: ISENTRESS 100 mg - bottle labeling
Danish: ISENTRESS 100 mg - flaskeetiket
English: Weight based dosing, see dosing table for granules for oral suspension 19 *Number of patients with intensive pharmacokinetic (PK) results at the final recommended dose.
Danish: Vægtbaseret dosering, se doseringstabellen for granulat til oral suspension * Antal patienter med intensive farmakokinetiske resultater ved den anbefalede slutdosis.
English: 0.8 mL (8 mg) twice daily
Danish: 0,8 ml (8 mg) to gange dagligt
English: Film-coating - Lactose monohydrate - Hypromellose 2910 - Titanium dioxide - Triacetin - Iron oxide yellow - Black iron oxide
Danish: Filmovertræk - Lactosemonohydrat - Hypromellose 2910 - Titaniumdioxid - Triacetin - Gul jernoxid - Sort jernoxid
English: Emtricitabine/tenofovir disaproxil fumarate was identified to increase raltegravir 1,200 mg once daily bioavailability by 12%, however its impact is not clinically meaningful.
Danish: Emtricitabin/tenofovirdisaproxilfumarat blev påvist at øge biotilgængeligheden af raltegravir 1,200 mg en gang dagligt med 12%.
English: ISENTRESS chewable tablets can be administered with or without food (see section 5.2).
Danish: ISENTRESS tyggetabletter kan administreres med eller uden mad (se pkt.
English: Recommendations concerning co-administration tipranavir /ritonavir (raltegravir 400 mg Twice Daily)
Danish: Anbefalinger vedrørende samtidig administration tipranavir /ritonavir (raltegravir 400 mg to gange dagligt)
English: With respect to the primary efficacy endpoint, the proportion of patients achieving HIV RNA < 40 copies/mL at Week 48 was 472/531(88.9 %) in the group receiving raltegravir 1,200 mg once daily and 235/266 (88.3 %) in the group receiving raltegravir 400 mg twice daily.
Danish: Med hensyn til det primære endepunkt var andelen af patienter, der opnåede hiv-RNA < 40 kopier/ml i uge 48, 472/531(88,9%) i gruppen, der fik raltegravir 1.200 mg en gang dagligt, og 235/266 (88,3%) i gruppen, der fik raltegravir 400 mg to gange dagligt.
English: armpit and groin
Danish: Nyrer og urinveje
English: Co-administration of raltegravir with antacids containing divalent metal cations may reduce raltegravir absorption by chelation, resulting in a decrease of raltegravir plasma levels.
Danish: Samtidig administration af raltegravir og antacida, der indeholder divalente metalkationer, kan reducere absorptionen af raltegravir på grund af kelation, hvilket medfører et fald i raltegravirs plasmakoncetration.
English: 0.7 mL (7 mg) once daily
Danish: 0,7 ml (7 mg) en gang dagligt
English: Uncommon dizziness, headache, psychomotor hyperactivity amnesia, carpal tunnel syndrome, cognitive disorder, disturbance in attention, dizziness postural, dysgeusia, hypersomnia, hypoaesthesia, lethargy, memory impairment, migraine, neuropathy peripheral, paraesthesia, somnolence, tension headache, tremor, poor quality sleep
Danish: Amnesi, karpaltunnelsyndrom, kognitiv forstyrrelse, opmærksomhedsforstyrrelse, postural svimmelhed, dysgeusi, hypersomnia, hypæstesi, letargi, hukommelsessvækkelse, migræne, perifer neuropati, paræstesi, døsighed, spændingshovedpine, tremor, dårlig søvnkvalitet
English: Uncommon cachexia, diabetes mellitus, dyslipidaemia, hypercholesterolaemia, hyperglycaemia, hyperlipidaemia, hyperphagia, increased appetite, polydipsia, body fat disorder
Danish: Kakeksi, diabetes mellitus, dyslipidæmi, hyperkolesterolæmi, hyperglykæmi, hyperlipidæmi, hyperfagi, øget appetit, polydipsi, unormal fordeling af kropsfedt
English: • 2 mixing cups
Danish: • 2 blandebægre
English: Mean CD4 Cell Change (95 % CI), cells/mm
Danish: Gennemsnitlig ændring af CD4-tal (95% CI), celler/mm
English: The 100 mg chewable tablet can be divided into equal 50 mg doses.
Danish: 100 mg tyggetabletten kan deles i to lige store doser på 50 mg.
English: In some patients with advanced HIV infection and a history of opportunistic infection, signs and symptoms of inflammation from previous infections may occur soon after anti-HIV treatment is started.
Danish: Patienter med fremskreden hiv-infektion, som tidligere har haft en infektion, der kun forekommer under særlige betingelser (opportunistisk infektion), kan få tegn og symptomer på betændelse fra tidligere infektioner.
English: • When your supply of Isentress starts to run low, get more from your doctor or pharmacy.
Danish: • Når din Isentress er ved at være brugt op, skal du hente mere hos din læge eller på apoteket, fordi det er meget vigtigt ikke at være uden medicin, selv i kort tid.
English: Geometric Mean (%CV AUC (mg*hr/L)
Danish: Geometrisk gennemsnit (% CV AUC (mg*t/l)
English: maraviroc AUC  14% maraviroc C12hr  10% maraviroc Cmax ↓ 21%
Danish: maraviroc AUC 14% maraviroc C12t 10% maraviroc Cmax ↓21%
English: maraviroc AUC  14 % maraviroc C12hr  10 % maraviroc Cmax ↓ 21 %
Danish: maraviroc AUC  14% maraviroc C12t  10% maraviroc Cmax ↓ 21%
English: For analysis by prognostic factors, virologic failures were carried forward for percent < 40 copies/mL.
Danish: Ved den prognostiske analyse blev virologisk svigt analyseret som "carry forward" for procent med < 40 kopier/ml.
English: Geometric Mean (% CV Ctrough (ng/mL)
Danish: Geometrisk gennemsnit (% CV Cdal (ng/ml)
English: 25 mg chewable tablets:
Danish: 25 mg tyggetabletter:
English: Randomisation was stratified by screening HIV RNA level (≤ 50,000 copies/mL; and > 50,000 copies/mL) and by hepatitis B or C status (positive or negative).
Danish: Randomisering blev stratificeret ved screening af hiv-RNA-koncentrationen (≤50.000 kopier/ml og >50.000 kopier/ml) og ved hepatitis Beller C-status (positiv eller negativ).
English: No dose adjustment required for raltegravir or boceprevir.
Danish: Dosisjustering af raltegravir eller boceprevir er ikke nødvendig.
English: Results of Week 48 and 96 analyses
Danish: Resultater af uge 48- og 96-analyserne
English: tipranavir /ritonavir (raltegravir 400 mg Twice Daily)
Danish: tipranavir /ritonavir (raltegravir 400 mg to gange dagligt)
English: Co-administration of raltegravir with aluminium and magnesium antacids resulted in reduced raltegravir plasma levels.
Danish: Administration af raltegravir sammen med aluminium- og magnesiumholdige antacida medførte nedsat plasmakoncentration af raltegravir.
English: Sixteen (16) neonates received 2 doses of ISENTRESS in first 2 weeks of life, and 26 neonates received 6 weeks of daily dosing; all were followed for 24 weeks.
Danish: 5.2) havde egnede spædbørn en gestationsalder på mindst 37 uger og vejede mindst 2 kg. 16 nyfødte fik 2 doser ISENTRESS i løbet af de 2 første leveuger, og 26 nyfødte fik 6 ugers daglig dosering.
English: Refer to the 400 mg tablet and granules for oral suspension SmPCs for additional dosing information.
Danish: Se produktresuméerne for 400 mg tabletten og granulatet til oral suspension for yderligere oplysninger om dosering.
English: Co-administration of raltegravir with other agents that increase gastric pH (e.g., omeprazole and famotidine) may increase the rate of raltegravir absorption and result in increased plasma levels of raltegravir (see Table 3).
Danish: Samtidig administration af raltegravir og andre lægemidler, der øger pH i mavesækken (f.eks. omeprazol og famotidin), kan øge absorptionen af raltegravir og resultere i øget plasmakoncentration af raltegravir (se tabel 3).
English: • increased liver blood tests; abnormal white blood cells; increased fat levels in blood; increased level of enzyme from salivary glands or pancreas
Danish: • Forhøjede leverblodprøver, unormalt antal hvide blodlegemer, øget indhold af fedt i blodet,
English: Your doctor will tell you the right dose at each check-up after weighing your child. Be sure to keep your doctor's appointments so you get new dosing information as your child grows.
Danish: Sørg for at overholde alle besøg hos lægen, så du får nye doseringsoplysninger i takt med, at dit barn vokser.
English: Demographics Age (years), median [range] Male Gender Race Caucasian Black Baseline Characteristics Plasma HIV-1 RNA (log10 copies/mL), mean [range] CD4 cell count (cells/mm
Danish: Demografi Alder (år), median [interval] Køn: mand Race Hvid Sort Karakteristika ved baseline Plasma hiv-1 RNA (log10 kopier/ml), middelværdi [interval] CD4-celletal (celler/mm
English: 100 mg chewable tablets:
Danish: 100 mg tyggetabletter:
English: Co-administration of raltegravir with other agents that increase gastric pH (e.g., omeprazole and famotidine) may increase the rate of raltegravir absorption and result in increased plasma levels of raltegravir (see Table 1).
Danish: Samtidig administration af raltegravir og andre lægemidler, der øger pH i mavesækken (f.eks. omeprazol og famotidin), kan øge absorptionen af raltegravir og resultere i øget plasmakoncentration af raltegravir (se tabel 1).
English: H2 BLOCKERS AND PROTON PUMP INHIBITORS omeprazole (raltegravir 400 mg Twice Daily)
Danish: H2-BLOKKERE OG PROTONPUMPEHÆMMERE omeprazol (raltegravir 400 mg to gange dagligt)
English: The chewable tablets are available in 25 mg and scored 100 mg strengths.
Danish: Tyggetabletterne fås i 25 mg og 100 mg med delekærv.
English: No dose adjustment required for raltegravir or maraviroc.
Danish: Dosisjustering af raltegravir eller maraviroc er ikke nødvendig.
English: Refer to the chewable tablet and granules for oral suspension SmPCs for additional dosing information.
Danish: Se produktresuméerne for tyggetabletten og granulatet til oral suspension for yderligere oplysninger om dosering.
English: Mean CD4 Cell Change (95 % CI), cells/mm All patients
Danish: Gennemsnitlig ændring i CD4-celletal (95 % CI), celler/mm Alle patienter
English: Ethinyl Estradiol AUC  2 % Ethinyl Estradiol Cmax ↑ 6 % Norelgestromin AUC ↑ 14 % Norelgestromin Cmax ↑ 29 %
Danish: Ethinylestradiol AUC  2% Ethinylestradiol Cmax ↑ 6% Norelgestromin AUC ↑ 14% Norelgestromin Cmax ↑ 29%
English: • Keep the bottle tightly closed, with the desiccant in order to protect from moisture.
Danish: • Hold flasken tæt tillukket og behold tørremidlet i flasken for at beskytte mod fugt.
English: Isentress is also available in a 400 mg tablet, a 600 mg tablet and in a chewable tablet.
Danish: Isentress fås også som en 400 mg tablet, en 600 mg tablet og som en tyggetablet.
English: 1 mL (10 mg) twice daily
Danish: 1 ml (10 mg) to gange dagligt
English: 0.4 mL (4 mg) once daily
Danish: 0,4 ml (4 mg) en gang dagligt
English: Table 4 Efficacy Outcome at Weeks 48 and 96
Danish: Tabel 4 Effektresultater ved uge 48 og 96
English: Geometric mean (%CV AUC0-12hr (μM●hr)
Danish: Geometrisk middelværdi (%CV†) AUC0-12t (μM●t)
English: Raltegravir 400 mg twice daily (N = 266)
Danish: Raltegravir 400 mg to gange dagligt (N = 266)
English: Uncommon abdominal distention, abdominal pain, diarrhoea, flatulence, nausea, vomiting, dyspepsia gastritis, abdominal discomfort, abdominal pain upper, abdominal tenderness, anorectal discomfort, constipation, dry mouth, epigastric discomfort, erosive duodenitis, eructation, gastroesophageal reflux disease, gingivitis, glossitis, odynophagia, pancreatitis acute, peptic ulcer, rectal haemorrhage
Danish: Gastritis, abdominale gener, øvre abdominal smerte, abdominal ømhed, anorektale gener, obstipation, mundtørhed, epigastrisk ubehag, erosiv duodenit, eructatio, gastroøsofageal refluks, gingivit, glossit, odynofagi, akut pankreatit, ulcus pepticum, rektalblødning
English: Keep the bottle tightly closed, with the desiccant in order to protect from moisture.
Danish: Hold flasken tæt tillukket og behold tørremidlet i flasken for at beskytte mod fugt.
English: Talk to your doctor about other antacids you can take.
Danish: Tal med lægen om andre lægemidler, du kan tage mod for meget mavesyre.
English: Table 2 Efficacy Outcome at Weeks 48 and 96
Danish: Tabel 2 Effektresultater ved uge 48 og 96
English: No dosage adjustment required for raltegravir (400 mg twice daily and 1,200 mg once daily) or hormonal contraceptives (estrogen- and/or progesterone-based).
Danish: Dosisjustering af raltegravir (400 mg to gange dagligt og 1.200 mg en gang dagligt) eller hormonelle antikonceptionsmidler (østrogen- og/eller progesteronbaserede) er ikke nødvendig.
English: Snap the lid of the mixing cup shut.
Danish: Klik låget på blandebægeret på plads.
English: Hold the syringe with tip up.
Danish: Vend sprøjten med spidsen opad.
English: ISENTRESS 100 mg granules Raltegravir
Danish: ISENTRESS 100 mg granulat raltegravir
English: ≤ 100,000 copies/mL CD4-count ≤ 200 cells/mm > 200 cells/mm Viral Subtype Clade B Non-Clade B 93.6 (89.1, 96.6) 93.2 (84.9, 97.8) 89.5 (84.1, 93.6) 94.4 (86.2, 98.4)
Danish: Karakteristika ved baseline Hiv-RNA > 100.000 kopier/ml 86,7 (80,0; 91,8) 83,8 (73,4; 91,3) 84,7 (77,5; 90,3) 82,9 (72,0; 90,8) ≤ 100.000 kopier/ml 97,2 (94,9; 98,7) 97,7 (94,3; 99,4) 91,9 (88,5; 94,5) 93,0 (89,1; 97,1) CD4-celletal ≤ 200 celler/mm > 200 celler/mm Virusundertype Clade B Non-Clade B 93,6 (89,1; 96,6) 93,2 (84,9; 97,8) 89,5 (84,1; 93,6) 94,4 (86,2; 98,4)
English: Uncommon alanine aminotransferase increased, atypical lymphocytes, aspartate aminotransferase increased, blood triglycerides increased, lipase increased, blood pancreatic amylase increased absolute neutrophil count decreased, alkaline phosphatase increased, blood albumin decreased, blood amylase increased, blood bilirubin increased, blood cholesterol increased, blood creatinine increased, blood glucose increased, blood urea nitrogen increased, creatine phosphokinase increased, fasting blood glucose increased, glucose urine present, high density lipoprotein increased, international normalised ratio increased, low density lipoprotein increased, platelet count decreased, red blood cells urine positive, waist circumference increased, weight increased, white blood cell count decreased
Danish: Reduceret absolut neutrofilværdi, forhøjet alkalisk fosfatase, fald i albumin, forhøjet blodamylase, forhøjet bilirubin i blodet, forhøjet kolesteroltal, stigning i serumkreatinin, stigning i blodsukker, stigning i karbamidkvælstof, forhøjet kreatinfosfokinase, stigning i fasteblodsukker, sukker i urinen, stigning i HDL, forhøjet international normaliseret ratio (INR), stigning i LDL, fald i antal blodplader, positiv test for røde blodlegemer i urinen, øget abdominalomfang, vægtøgning, fald i antal hvide blodlegemer
English: Slowly push the plunger to make the air come out.
Danish: Pres al luften ud af sprøjten ved at trykke stemplet langsomt opad.
English: CCR5 inhibitors maraviroc (raltegravir 400 mg Twice Daily)
Danish: CCR5-hæmmere maraviroc (raltegravir 400 mg to gange dagligt)